Days
Speakers
Session Type
Search
Mon 11 Nov 2019
Mon 11
Tue 12 Nov 2019
Tue 12
Wed 13 Nov 2019
Wed 13
All
Type
Theatre 1
No focus area
Workshop
Oral
Expert
Plenary
Catering and Social
Nurse
Other
Symposium
Not specified
Hide all
Show all
Monday 11 November
5 sessions
12:45 - 13:45
Pituitary: The New & the Old
Sandoz
Syndicate 1 & 2
Pituitary: The New & the Old
Nelson’s syndrome
Niki Karavitaki
Birmingham, UK
Pituitary: The New & the Old
BRAF inhibitors in Papillary Craniopharyngiomas
Speaker TBC
Pituitary: The New & the Old
Checkpoint inhibitor related hypophysitis
Robert Murray
Leeds, UK
Pituitary: The New & the Old
Panel Discussion and Q&A
All speakers
12:45 - 13:45
Neuroendocrine tumours for the general endocrinologist
Advanced Accelerator Applications
Syndicate 3 & 4
Neuroendocrine tumours for the general endocrinologist
Welcome & Introduction
Ashley Grossman
London, UK
Neuroendocrine tumours for the general endocrinologist
Overview & management of NETS
Maralyn Druce
London, UK
Neuroendocrine tumours for the general endocrinologist
Q&A
Neuroendocrine tumours for the general endocrinologist
GEP-NETs and PRRT
Alia Munir
Sheffield, UK
Neuroendocrine tumours for the general endocrinologist
Q&A
12:45 - 13:55
Oral Poster Presentations
SfE Theatre
16:45 - 17:05
SfE Connect
SfE Theatre
17:05 - 17:35
Membership of the European Society of Endocrinology - How can it benefit you?
European Society of Endocrinology
SfE Theatre
Chair: Helen Gregson
Theatre 1
Tuesday 12 November
7 sessions
10:30 - 11:05
Pfizer-Sponsored Presentation
SfE Theatre
12:40 - 13:25
David Anderson Book Launch
SfE Theatre
13:25 - 14:40
Oral Poster Presentations
SfE Theatre
13:35 - 14:35
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Pfizer
Syndicate 1 & 2
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
A brief history of ACROSTUDY
Professor Lely
Erasmus University MC, The Netherlands
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Key outcomes: exploring safety and treatment outcomes
Professor Ross
Sheffield, UK
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Impact of treatment on glucose metabolism
Professor Ross
Sheffield, UK
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Q&A
13:35 - 14:35
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
HRA Pharma Rare Diseases-sponsored
Syndicate 3 & 4
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Starting a movement in Cushing’s syndrome
John Wass
Oxford, United Kingdom
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
The patient journey in Cushing’s syndrome: Can we change the route to a new destination?
Menai Owen-Jones
Cardiff & Bristol, UK
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Getting it right first time: Harnessing experience and expertise to improve outcomes
John Newell-Price
Sheffield, UK
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
From the first step: Designing management strategies for the future
Joan Grieve
London, UK
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Collective thinking: How we can build Cushing’s syndrome management strategies with confidence
John Wass
Oxford, United Kingdom
16:15 - 16:45
Advanced Practice in Endocrinology Nursing Book Launch
SfE Theatre
Dr Sofia Llahana
16:45 - 17:15
MTEditor Q&A session
SfE Theatre
Wednesday 13 November
3 sessions
10:20 - 10:50
Pfizer-Sponsored Presentation
SfE Theatre
13:10 - 14:15
Oral Poster Presentations
SfE Theatre
13:20 - 14:20
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Bristol-Myers Squibb
Syndicate 1 & 2
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
The cancer treatment landscape: Current status of immunotherapies and a practical guide to immune-related endocrinopathies
Dr Higham
Liverpool and Sheffield, UK
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Examples from the clinic and Q&A
Dr Higham
Liverpool and Sheffield, UK
Maralyn Druce
London, UK
Mon 11
12:50
Neuroendocrine tumours for the general endocrinologist
Overview & management of NETS
Maralyn Druce
London, UK
Joan Grieve
London, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
From the first step: Designing management strategies for the future
Joan Grieve
London, UK
Ashley Grossman
London, UK
Mon 11
12:45
Neuroendocrine tumours for the general endocrinologist
Welcome & Introduction
Ashley Grossman
London, UK
Dr Higham
Liverpool and Sheffield, UK
Wed 13
13:20
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
The cancer treatment landscape: Current status of immunotherapies and a practical guide to immune-related endocrinopathies
Dr Higham
Liverpool and Sheffield, UK
Wed 13
13:40
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Examples from the clinic and Q&A
Dr Higham
Liverpool and Sheffield, UK
Niki Karavitaki
Birmingham, UK
Mon 11
12:45
Pituitary: The New & the Old
Nelson’s syndrome
Niki Karavitaki
Birmingham, UK
Professor Lely
Erasmus University MC, The Netherlands
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
A brief history of ACROSTUDY
Professor Lely
Erasmus University MC, The Netherlands
Alia Munir
Sheffield, UK
Mon 11
13:15
Neuroendocrine tumours for the general endocrinologist
GEP-NETs and PRRT
Alia Munir
Sheffield, UK
Robert Murray
Leeds, UK
Mon 11
13:15
Pituitary: The New & the Old
Checkpoint inhibitor related hypophysitis
Robert Murray
Leeds, UK
John Newell-Price
Sheffield, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Getting it right first time: Harnessing experience and expertise to improve outcomes
John Newell-Price
Sheffield, UK
Menai Owen-Jones
Cardiff & Bristol, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
The patient journey in Cushing’s syndrome: Can we change the route to a new destination?
Menai Owen-Jones
Cardiff & Bristol, UK
Professor Ross
Sheffield, UK
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Key outcomes: exploring safety and treatment outcomes
Professor Ross
Sheffield, UK
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Impact of treatment on glucose metabolism
Professor Ross
Sheffield, UK
All speakers
Mon 11
13:30
Pituitary: The New & the Old
Panel Discussion and Q&A
All speakers
Speaker TBC
Mon 11
13:00
Pituitary: The New & the Old
BRAF inhibitors in Papillary Craniopharyngiomas
Speaker TBC
John Wass
Oxford, United Kingdom
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Starting a movement in Cushing’s syndrome
John Wass
Oxford, United Kingdom
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Collective thinking: How we can build Cushing’s syndrome management strategies with confidence
John Wass
Oxford, United Kingdom
Workshop
0
Oral
1
Mon 11
12:45
Oral Poster Presentations
SfE Theatre
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
3
Mon 11
16:45
SfE Connect
SfE Theatre
Tue 12
10:30
Pfizer-Sponsored Presentation
SfE Theatre
Tue 12
12:40
David Anderson Book Launch
SfE Theatre
Symposium
5
Mon 11
12:45
Pituitary: The New & the Old
Sandoz
Syndicate 1 & 2
Mon 11
12:45
Pituitary: The New & the Old
Nelson’s syndrome
Niki Karavitaki
Birmingham, UK
Mon 11
13:00
Pituitary: The New & the Old
BRAF inhibitors in Papillary Craniopharyngiomas
Speaker TBC
Mon 11
13:15
Pituitary: The New & the Old
Checkpoint inhibitor related hypophysitis
Robert Murray
Leeds, UK
Mon 11
13:30
Pituitary: The New & the Old
Panel Discussion and Q&A
All speakers
Mon 11
12:45
Neuroendocrine tumours for the general endocrinologist
Advanced Accelerator Applications
Syndicate 3 & 4
Mon 11
12:45
Neuroendocrine tumours for the general endocrinologist
Welcome & Introduction
Ashley Grossman
London, UK
Mon 11
12:50
Neuroendocrine tumours for the general endocrinologist
Overview & management of NETS
Maralyn Druce
London, UK
Mon 11
13:10
Neuroendocrine tumours for the general endocrinologist
Q&A
Mon 11
13:15
Neuroendocrine tumours for the general endocrinologist
GEP-NETs and PRRT
Alia Munir
Sheffield, UK
Mon 11
13:35
Neuroendocrine tumours for the general endocrinologist
Q&A
Tue 12
13:35
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Pfizer
Syndicate 1 & 2
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
A brief history of ACROSTUDY
Professor Lely
Erasmus University MC, The Netherlands
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Key outcomes: exploring safety and treatment outcomes
Professor Ross
Sheffield, UK
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Impact of treatment on glucose metabolism
Professor Ross
Sheffield, UK
Tue 12
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Q&A
Tue 12
13:35
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
HRA Pharma Rare Diseases-sponsored
Syndicate 3 & 4
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Starting a movement in Cushing’s syndrome
John Wass
Oxford, United Kingdom
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
The patient journey in Cushing’s syndrome: Can we change the route to a new destination?
Menai Owen-Jones
Cardiff & Bristol, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Getting it right first time: Harnessing experience and expertise to improve outcomes
John Newell-Price
Sheffield, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
From the first step: Designing management strategies for the future
Joan Grieve
London, UK
Tue 12
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Collective thinking: How we can build Cushing’s syndrome management strategies with confidence
John Wass
Oxford, United Kingdom
Wed 13
13:20
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Bristol-Myers Squibb
Syndicate 1 & 2
Wed 13
13:20
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
The cancer treatment landscape: Current status of immunotherapies and a practical guide to immune-related endocrinopathies
Dr Higham
Liverpool and Sheffield, UK
Wed 13
13:40
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Examples from the clinic and Q&A
Dr Higham
Liverpool and Sheffield, UK
No Session Type
6
Mon 11
17:05
Membership of the European Society of Endocrinology - How can it benefit you?
European Society of Endocrinology
SfE Theatre
Chair: Helen Gregson
Theatre 1
Tue 12
13:25
Oral Poster Presentations
SfE Theatre
Tue 12
16:15
Advanced Practice in Endocrinology Nursing Book Launch
SfE Theatre
Dr Sofia Llahana
Tue 12
16:45
MTEditor Q&A session
SfE Theatre
Wed 13
10:20
Pfizer-Sponsored Presentation
SfE Theatre
Wed 13
13:10
Oral Poster Presentations
SfE Theatre
0 result(s) found.
Please wait...
×
-
×
Abstracts from this event
Abstracts from other events
Session starts at:
Abstract time:
Event:
×